Department of Pharmaceutical Sciences, University of Cincinnati College of Pharmacy, 136 Health Professions Building, 3225 Eden Ave., Cincinnati, OH 45267-0004, USA.
Department of Dermatology, University of Cincinnati College of Medicine, 231 Albert Sabin Way, ML-0592, Cincinnati, OH 45267-0592, USA.
Int J Mol Sci. 2009 Sep 15;10(9):4066-4087. doi: 10.3390/ijms10094066.
Skin pigmentary abnormalities are seen as aesthetically unfavorable and have led to the development of cosmetic and therapeutic treatment modalities of varying efficacy. Hence, several putative depigmenting agents aimed at modulating skin pigmentation are currently being researched or sold in commercially available products. In this review we will discuss the regulation of processes that control skin complexion coloration. This includes direct inhibition of tyrosinase and related melanogenic enzymes, regulation of melanocyte homeostasis, alteration of constitutive and facultative pigmentation and down-regulation of melanosome transfer to the keratinocytes. These various processes, in the complex mechanism of skin pigmentation, can be regulated individually or concomitantly to alter complexion coloration and thus ameliorate skin complexion diseases.
皮肤色素异常被视为美观上的不利因素,促使人们开发出各种具有不同疗效的美容和治疗方法。因此,目前有几种潜在的脱色剂被用于调节皮肤色素沉着,这些制剂有的正在研究中,有的已被制成商品出售。在这篇综述中,我们将讨论控制皮肤肤色的过程的调节。这包括直接抑制酪氨酸酶和相关的黑色素生成酶、调节黑素细胞的动态平衡、改变固有和兼性色素沉着以及下调黑色素体向角质形成细胞的转移。这些不同的过程,在皮肤色素沉着的复杂机制中,可以单独或同时调节,以改变肤色,从而改善皮肤色素沉着疾病。